| Mitochondria, oxidative stress and neurodegeneration | 2012/11/01 | English | 501 |
| Central nervous system manifestations of COVID-19: A systematic review | 2020/06/01 | English | 493 |
| Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss | 2005/06/01 | English | 477 |
| Carbon monoxide intoxication: An updated review | 2007/11/01 | English | 443 |
| Effects of transcranial direct current stimulation on working memory in patients with Parkinson's disease | 2006/11/01 | English | 419 |
| Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis | 2017/01/01 | English | 378 |
| Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies | 2006/06/01 | English | 375 |
| Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change | 2005/04/01 | English | 371 |
| Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion | 2003/12/01 | English | 370 |
| Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis | 2022/03/01 | English | 312 |
| Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders | 2007/06/01 | English | 310 |
| The “posture second” strategy: A review of wrong priorities in Parkinson's disease | 2006/10/01 | English | 300 |
| The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke | 2010/12/01 | English | 299 |
| Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics | 2011/04/01 | English | 281 |
| Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia | 2005/06/01 | English | 277 |
| The epidemiology of dementia associated with Parkinson disease | 2010/02/01 | English | 271 |
| Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures | 2011/07/01 | English | 259 |
| Elevated red blood cell distribution width predicts mortality in persons with known stroke | 2009/02/01 | English | 238 |
| Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants | 2017/01/01 | English | 235 |
| Minamata disease revisited: An update on the acute and chronic manifestations of methyl mercury poisoning | 2007/11/01 | English | 233 |
| Quality of life and depression in Parkinson's disease | 2006/10/01 | English | 232 |
| Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy | 2013/05/01 | English | 219 |
| General mechanisms of axonal damage and its prevention | 2005/06/01 | English | 218 |
| Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective | 2012/06/01 | English | 216 |
| Sarin experiences in Japan: Acute toxicity and long-term effects | 2006/11/01 | English | 215 |
| Effects of fasudil in acute ischemic stroke: Results of a prospective placebo-controlled double-blind trial | 2005/11/01 | English | 214 |
| Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance | 2012/07/01 | English | 205 |
| The King–Devick test and sports-related concussion: Study of a rapid visual screening tool in a collegiate cohort | 2011/10/01 | English | 205 |
| Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale | 2013/08/01 | English | 204 |
| Mortality in Friedreich Ataxia | 2011/08/01 | English | 199 |